Product
Tebipenem
2 clinical trials
5 indications
Indication
Relative BioavailabilityIndication
DiabetesIndication
Wound InfectionIndication
Healthy Control ParticipantsClinical trial
Relative Bioavailability of Tebipenem (SPR994) Crushed Tablet Formulation Administered by Nasogastric Tube in Healthy SubjectsStatus: Completed, Estimated PCD: 2022-06-01
Clinical trial
Pharmacokinetics and Soft-Tissue Penetration of Tebipenem (SPR994) in Healthy Volunteer Subjects and Diabetic Patients With Lower Limb InfectionsStatus: Completed, Estimated PCD: 2022-08-30